Effective Assay Screening with Cultured 3D Cell Clusters

13 November 2017

Watch this video to learn more about the drug and product screening process at Likarda, a contract research organization. Dr Lisa Stehno-Bittel, President & CEO of Likarda, discusses the problems of screening drugs for efficacy. Due to the nature of cultured cells, it is very difficult to predict which drugs you’re working with are finally going to work in the human body. By employing the BioTek Cytation 5, Likarda is able to offer the most sophisticated 3D results, efficiently testing drugs in a representative manner.